BridgeMD
New treatment option for Eating Disorders in Adolescence
Official title Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program
ClinicalTrials.gov ID: NCT06431854
What this study is testing
- What it's testing
- The aim of this study is to investigate the efficacy, efficiency, and patient experience of a new intervention program on adolescents with high-complexity eating disorders (ED). A prospective group of adolescents with ED (N=60) will follow this treatment program including four different phases: 1) Inpatient treatment; 2) Family Treatment Apartment; 3) Home Treatment; 4) Recovery within the community.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 17
You may be able to join if
- for the prospective experimental group:
- Patient diagnosed with an Eating Disorder (according to the DSM-5) through a semi-structured interview (K-SADS PL-5)
- Aged between 12 and 17 years old
- Both patients and parents are willing to participate in the study and sign the informed consent to accept participation
- Patient with a poor response to treatment, defined as having one of the following two conditions:
You likely can't join if
- for the prospective group:
- Acute ED pathology and biological decompensation that require urgent pediatric attention or admission to an acute psychiatric ward. Inclusion...
- Aged between 12 and 17 years old
- Diagnosed with an Eating Disorder (according to the DSM-5)
- Received treatment in Sant Joan de Déu between 2012 and 2022
- Patient with a poor response to treatment, defined as having one of the following two conditions:
See the full eligibility criteria
- for the prospective experimental group:
- Patient diagnosed with an Eating Disorder (according to the DSM-5) through a semi-structured interview (K-SADS PL-5)
- Aged between 12 and 17 years old
- Both patients and parents are willing to participate in the study and sign the informed consent to accept participation
- Patient with a poor response to treatment, defined as having one of the following two conditions:
- undergoing over a year of treatment, including partial and total hospitalization, without symptom stabilization, experiencing severe psychological distress, eating symptomatology, comorbidities, or family dysfunction...
- undergoing more than three admissions without symptom stabilization (clinical improvement of at least 50 on the CGAS functioning scale).
- for the prospective group:
- Acute ED pathology and biological decompensation that require urgent pediatric attention or admission to an acute psychiatric ward. Inclusion criteria for the retrospective control group:
- Aged between 12 and 17 years old
- Diagnosed with an Eating Disorder (according to the DSM-5)
- Received treatment in Sant Joan de Déu between 2012 and 2022
- Patient with a poor response to treatment, defined as having one of the following two conditions:
- undergoing over a year of treatment, including partial or total hospitalization, without achieving stabilization of ED symptomatology (needing high-intensive treatment units i.e. not being able to follow individual...
- undergoing more than three admissions without symptom stabilization once referred to partial hospitalization in less than one year, including a similar psychological state and characteristics as the first condition...
- Missingness of 20% or more of the required data
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Spain
Compensation & support
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.